This announcement is a separate document:
Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer STAHL NEIL
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Price
Unlock the Full List
Latest
10:02
The offshore Chinese yuan rebounded about 100 points against the US dollar from its daily low, recovering the 7.35 level, currently reported at 7.3467 yuan.
10:01
The net Buy amount of southbound funds reached 3.2 billion Hong Kong dollars.
10:01
Hong Kong stocks in the Contract Research Organizations sector surged, with WUXI BIO (02269.HK) up over 4%, WUXI APPTEC (02359.HK) up over 2%, and Joinn Laboratories (06127.HK) and TIGERMED (03347.HK) both up over 1%.
WUXI BIO+3.52%